- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr James Auran Discusses the Transition of Ophthalmic Care to an Outpatient Specialty
James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, outlines the benefits and challenges of transferring ophthalmic care to outpatient facilities.
Transitioning to an outpatient model provides opportunities for savings and efficiency, said James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma.
Transcript
As ophthalmology has evolved into an outpatient specialty over the past few decades, what challenges have come along with this transition?
I wouldn't look at it so much as challenges, as much as the incredible opportunities for cost savings, for efficiency, and for just making it a more patient-friendly environment. I think it's been a tremendous advance. I've seen very few downsides, although there is one small one with trauma which we could go into. Ophthalmologists, in general, have shied away from caring for trauma. It's disruptive to your practice to have a patient come in who needs immediate care, especially if it's complex. The skill set involved is specialized, and it's not something you want to do once every 2 years. When doctors were hospital-based, it was a little bit more, it'd be more common in their practice to encounter this. The trend toward being in private office groups and in surgery centers has sort of put a lot of eye doctors out of touch with trauma care.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
